Patent in Israel granted for DNA-FACE™
- BioVentures
- Mar 9, 2021
- 1 min read
Updated: Mar 21, 2021
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes has been granted with Israeli patent. We are awaiting for issuing the patent number (the application number no 248011).
Comments